Imricor Medical Systems Inc
ASX:IMR
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.415
0.94
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one IMR stock under the Base Case scenario is 0.46 AUD. Compared to the current market price of 0.93 AUD, Imricor Medical Systems Inc is Overvalued by 51%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Imricor Medical Systems Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for IMR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Imricor Medical Systems Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Imricor Medical Systems Inc
Balance Sheet Decomposition
Imricor Medical Systems Inc
Current Assets | 4.1m |
Cash & Short-Term Investments | 1.5m |
Receivables | 312.1k |
Other Current Assets | 2.3m |
Non-Current Assets | 3.6m |
PP&E | 2.9m |
Other Non-Current Assets | 727.5k |
Current Liabilities | 2.8m |
Accounts Payable | 757k |
Accrued Liabilities | 1.4m |
Other Current Liabilities | 714.1k |
Non-Current Liabilities | 11.3m |
Long-Term Debt | 7.8m |
Other Non-Current Liabilities | 3.5m |
Earnings Waterfall
Imricor Medical Systems Inc
Revenue
|
824.3k
USD
|
Cost of Revenue
|
-1.7m
USD
|
Gross Profit
|
-913.4k
USD
|
Operating Expenses
|
-14.9m
USD
|
Operating Income
|
-15.8m
USD
|
Other Expenses
|
-4.5m
USD
|
Net Income
|
-20.3m
USD
|
Free Cash Flow Analysis
Imricor Medical Systems Inc
USD | |
Free Cash Flow | USD |
Imricor announced significant developments in Q1 of 2024, including the launch of new commercial sites and regulatory advancements in the Middle East and Europe. The company reported operating cash outflows of $4.7 million and secured $5.1 million from financing activities. With Saudi FDA approval and pending TGA clearance in Australia, Imricor aims to expand globally. A pivotal U.S. FDA trial for atrial flutter is underway, and the first ventricular tachycardia ablation with MRI guidance is planned. Despite delays, the commercialization effort is progressing with increased procedural volumes and new site activations scheduled throughout the year.
What is Earnings Call?
IMR Profitability Score
Profitability Due Diligence
Imricor Medical Systems Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Imricor Medical Systems Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
IMR Solvency Score
Solvency Due Diligence
Imricor Medical Systems Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Score
Imricor Medical Systems Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IMR Price Targets Summary
Imricor Medical Systems Inc
According to Wall Street analysts, the average 1-year price target for IMR is 1.1 AUD with a low forecast of 1.09 AUD and a high forecast of 1.13 AUD.
Dividends
Current shareholder yield for IMR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
IMR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The company is headquartered in Burnsville, Minnesota. The company went IPO on 2019-08-30. The firm is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The firm sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.
Officers
The intrinsic value of one IMR stock under the Base Case scenario is 0.46 AUD.
Compared to the current market price of 0.93 AUD, Imricor Medical Systems Inc is Overvalued by 51%.